Proportion of patients with prosthetic joint infection eligible for adjuvant phage therapy: a French single-centre retrospective study DOI Creative Commons

A. Le Pogam,

Fernanda Pereira Medina,

A. Belkacem

et al.

BMC Infectious Diseases, Journal Year: 2024, Volume and Issue: 24(1)

Published: Sept. 5, 2024

Language: Английский

A Comprehensive Review on Phage Therapy and Phage-Based Drug Development DOI Creative Commons
Longzhu Cui, Shinya Watanabe, Kazuhiko Miyanaga

et al.

Antibiotics, Journal Year: 2024, Volume and Issue: 13(9), P. 870 - 870

Published: Sept. 11, 2024

Phage therapy, the use of bacteriophages (phages) to treat bacterial infections, is regaining momentum as a promising weapon against rising threat multidrug-resistant (MDR) bacteria. This comprehensive review explores historical context, modern resurgence phage and phage-facilitated advancements in medical technological fields. It details mechanisms action applications phages treating MDR particularly those associated with biofilms intracellular pathogens. The further highlights innovative uses vaccine development, cancer gene delivery vectors. Despite its targeted efficient approach, therapy faces challenges related stability, immune response, regulatory approval. By examining these areas detail, this underscores immense potential remaining hurdles integrating phage-based therapies into practices.

Language: Английский

Citations

17

New Frontiers in CRISPR: Addressing Antimicrobial Resistance with Cas9, Cas12, Cas13, and Cas14 DOI Creative Commons
Ahmed S.A. Ali Agha, Ali Al‐Samydai, Talal Aburjaı

et al.

Heliyon, Journal Year: 2025, Volume and Issue: 11(2), P. e42013 - e42013

Published: Jan. 1, 2025

The issue of antimicrobial resistance (AMR) poses a major challenge to global health, evidenced by alarming mortality predictions and the diminishing efficiency conventional drugs. CRISPR-Cas system has proven be powerful tool in addressing this challenge. It originated from bacterial adaptive immune mechanisms gained significant recognition scientific community. This review aims explore applications technologies combating AMR, evaluating their effectiveness, challenges, potential for integration into current strategies. We conducted comprehensive recent literature databases such as PubMed Web Science, focusing on studies that employ against AMR. offer transformative approach combat with extend beyond traditional Integrating these existing methods could significantly enhance our ability manage potentially reverse growing problem resistance. Future research should address technical ethical barriers facilitate safe effective clinical environmental applications. underscores necessity interdisciplinary collaboration international cooperation harness full fight superbugs.

Language: Английский

Citations

2

Tackling catheter‐associated urinary tract infections with next‐generation antimicrobial technologies DOI Creative Commons

Lina Duque-Sánchez,

Yue Qu, Nicolas H. Voelcker

et al.

Journal of Biomedical Materials Research Part A, Journal Year: 2023, Volume and Issue: 112(3), P. 312 - 335

Published: Oct. 26, 2023

Abstract Urinary catheters and other medical devices associated with the urinary tract such as stents are major contributors to nosocomial infections (UTIs) they provide an access path for pathogens enter bladder. Considering that catheter‐associated (CAUTIs) account approximately 75% of UTIs represent most common type healthcare‐associated infections, novel anti‐infective device technologies urgently required. The rapid rise antimicrobial resistance in context CAUTIs further highlights importance preventative strategies. In this review, risk factors pathogen colonization dissected, taking into nature mechanistics unique environment. Moreover, promising next‐generation strategies critically assessed, focusing particular on surface coatings. Finally, emerging approaches field their likely clinical impact examined.

Language: Английский

Citations

19

Engineering Phages to Fight Multidrug-Resistant Bacteria DOI Creative Commons
Huan Peng, Irene A. Chen, Udi Qimron

et al.

Chemical Reviews, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 16, 2024

Facing the global "superbug" crisis due to emergence and selection for antibiotic resistance, phages are among most promising solutions. Fighting multidrug-resistant bacteria requires precise diagnosis of bacterial pathogens specific cell-killing. Phages have several potential advantages over conventional antibacterial agents such as host specificity, self-amplification, easy production, low toxicity well biofilm degradation. However, narrow range, uncharacterized properties, risks from exponential replication evolution natural phages, currently limit their applications. Engineering can not only enhance range improve phage efficacy, but also confer new functions. This review first summarizes major engineering techniques including both chemical modification genetic engineering. Subsequent sections discuss applications engineered pathogen detection ablation through interdisciplinary approaches synthetic biology nanotechnology. We future directions persistent challenges in ongoing exploration control.

Language: Английский

Citations

8

Phage Delivery Strategies for Biocontrolling Human, Animal, and Plant Bacterial Infections: State of the Art DOI Creative Commons
Marta M. D. C. Vila,

Liliane M. N. Balcão,

Victor M. Balcão

et al.

Pharmaceutics, Journal Year: 2024, Volume and Issue: 16(3), P. 374 - 374

Published: March 8, 2024

This review aims at presenting the main strategies that are currently available for delivery of bacteriophages to combat bacterial infections in humans, animals, and plants. It can be seen routes phage topical, oral, systemic, airways humans. In topical oral most used. To plant species, spraying plant’s phyllosphere or drenching soil commonly used methods. both therapy biocontrol using phages, very promising results have been obtained so far. However, more experiments needed establish forms treatment doses, among other parameters. Furthermore, general, there is a lack specific standards use phages infections.

Language: Английский

Citations

7

The power of phages: revolutionizing cancer treatment DOI Creative Commons
Md. Sharifull Islam, Jie Fan, Fan Pan

et al.

Frontiers in Oncology, Journal Year: 2023, Volume and Issue: 13

Published: Nov. 15, 2023

Cancer is a devastating disease with high global mortality rate and projected to increase further in the coming years. Current treatment options, such as chemotherapy radiation therapy, have limitations including side effects, variable effectiveness, costs, limited availability. There growing need for alternative treatments that can target cancer cells specifically fewer effects. Phages, infect bacteria but not eukaryotic cells, emerged promising therapeutics due their unique properties, specificity ease of genetic modification. Engineered phages transform by targeting while sparing healthy ones. Phages exhibit versatility nanocarriers, capable delivering therapeutic agents like gene immunotherapy, vaccines. are extensively used vaccine development, filamentous, tailed, icosahedral explored different antigen expression possibilities. filamentous bring benefits built adjuvant cost-effectiveness, multivalent formulations, feasibility oral administration, stability. Phage-based vaccines stimulate innate immune system engaging pattern recognition receptors on antigen-presenting enhancing phage peptide presentation B-cells T-cells. This review presents recent therapy advances challenges exploring its versatile tools potential.

Language: Английский

Citations

14

Bacteriophages in nature: recent advances in research tools and diverse environmental and biotechnological applications DOI
Monish Bisen,

Kusum Kharga,

Sakshi Mehta

et al.

Environmental Science and Pollution Research, Journal Year: 2024, Volume and Issue: 31(15), P. 22199 - 22242

Published: Feb. 27, 2024

Language: Английский

Citations

4

Phage treatment of multidrug-resistant bacterial infections in humans, animals, and plants: The current status and future prospects DOI Creative Commons

Omor Faruk,

Zilhas Ahmed Jewel,

Sanjoy Bairagi

et al.

Infectious Medicine, Journal Year: 2025, Volume and Issue: 4(1), P. 100168 - 100168

Published: Feb. 6, 2025

Phages, including the viruses that lyse bacterial pathogens, offer unique therapeutic advantages, their capacity to antibiotic-resistant bacteria and disrupt biofilms without harming host microbiota. The lack of new effective antibiotics growing limitations existing have refocused attention on phage therapy as an option in complex clinical cases such burn wounds, cystic fibrosis, pneumonia. This review describes preclinical studies which has been both human veterinary medicine, agricultural context. In addition, critical challenges, narrow range bacteriophages, possibility resistance, regulatory constraints widespread use therapy, are addressed. Future directions include optimizing through strategies ranging from cocktails broadening genetic modification, using phages vaccines or biocontrol agents. future, if can be efficiently delivered, maintained a stable state, phage-antibiotic synergy achieved, will much needed treatment options. However, successful implementation within current standards practice also require considerable development infrastructure greater public acceptance. closing, this highlights promise backup substitute for antibiotics. It proposes role significant adjunct to, even replacement for, treating multidrug-resistant infections.

Language: Английский

Citations

0

Comprehensive Review on Phage Therapy and Phage-Based Drug Development DOI Open Access
Longzhu Cui, Shinya Watanabe, Kazuhiko Miyanaga

et al.

Published: Aug. 27, 2024

Phage therapy, the use of bacteriophages (phages) to treat bacterial infections, is regaining momentum as a promising weapon against rising threat multidrug-resistant (MDR) bacteria. This comprehensive review explores historical context, modern resurgence phage and phage-facilitated advancements in medical technological fields. It details mechanisms action applications phages treating MDR particularly those associated with biofilms intracellular pathogens. The further highlights innovative uses vaccine development, cancer gene delivery vectors. Despite its targeted efficient approach, therapy faces challenges related stability, immune response, regulatory approval. By examining these areas detail, this underscores immense potential remaining hurdles integrating phage-based therapies into practices.

Language: Английский

Citations

3

IUPAC’s 2023 Top Ten Emerging Technologies in Chemistry DOI Open Access
Fernando Gomollón‐Bel

Chemistry International, Journal Year: 2023, Volume and Issue: 45(4), P. 14 - 22

Published: Oct. 1, 2023

Abstract This manuscript marks the five-year anniversary of IUPAC’s “Top Ten” initiative [1]. The new additions will grow list emerging technologies to fifty—all with a powerful potential make our world more sustainable and all suitable solutions current polycrisis [2]. past summer, theme IUPAC World Chemistry Congress in Hague was “Connecting Chemical Worlds,” which aligns almost perfectly goals Ten”—multidisciplinary research is key towards transitioning net-zero achieving United Nation’s Sustainable Development by 2030 [3]. Moreover, selection this year particularly promotes cross-collaboration chemistry create exciting that bridge gap between academia industry, while continuing competitiveness chemical manufacturers. From pool possible ideas, panel experts have selected following list, covering range fields from synthesis polymer health artificial intelligence. technology readiness level varies along different solutions—nevertheless, show provocative promise reimagine society.

Language: Английский

Citations

8